Skip to main content
Caplight Logo









RenewRx

RenewRx

Private
Denver, ColoradoHealthcare & Life Scienceshttps://renewrx.health

Last Round

Seed

Jul 18, 2025

Total Funding Raised

$1.25M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

RenewRx operates in Healthcare & Life Sciences and is based in Denver, Colorado. Its latest recorded funding round was an Accelerator round in June 2025.

RenewRx is a health technology company that provides a cardiometabolic care platform for maternal health, integrating real-time biometrics, nutrition insights, and behavior coaching to support patients during and after pregnancy.

Sector

Healthcare & Life Sciences

Verticals

Patient Engagement, Telemedicine, EHR & EMR, Revenue Cycle, Health IoT

Business Model

B2B

Customer Profile

Services & Consulting, Subscription SaaS

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

RenewRx Comparables

Compare RenewRx with similar companies based on industry and business-model similarity.

RenewRx comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
LilyLink
91%
Malama Health
89%
Delfina Care Inc
81%
Book a demo to see all comparables

For institutional investors. Book with your work email.

RenewRx Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedJul 18, 2025
AcceleratorJun 5, 2025
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

RenewRx Investors

Notable investors and investment history

RenewRx investors
InvestorRounds
MedTech InnovatorAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 26, 2026

    Monthly visitors grew 564% MoM, reaching 2.3K.

  • Mar 5, 2026

    Monthly visitors grew 88% MoM, from 781 to 1.5K.

Book a demo to see all signals

For institutional investors. Book with your work email.

RenewRx Filings

Explore SEC and related filing metadata, where available.

RenewRx filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about RenewRx's valuation, stock price, and market status.

Is RenewRx a public or private company?

RenewRx is a private company.

What is the current stock price of RenewRx?

RenewRx is a private company, so its shares have no public market price. Caplight tracks RenewRx's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is RenewRx worth (valuation)?

Valuation information for RenewRx is not publicly available.

Can I buy RenewRx stock?

RenewRx shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was RenewRx's last funding round?

RenewRx's most recent funding round was Seed on July 18, 2025.

Who are the main investors in RenewRx?

Key investors in RenewRx include MedTech Innovator.

Will RenewRx IPO soon?

No public IPO plans have been announced for RenewRx.

How can I track RenewRx secondary market activity?

Caplight tracks bids, offers, and trades in RenewRx's shares on secondary markets.

Firmographic Details

HeadquartersDenver, Colorado
Employee Range11
Year Founded2021
Last FundingJul 18, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?